Skip to main content
WST
NYSE Life Sciences

West Pharma Q2 Profit Jumps 17%, Guides FY EPS to $8.85-$9.05

Tom Rudovsky · Reported by dpa-AFX
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$360.2
Mkt Cap
$25.321B
52W Low
$211.1
52W High
$367.66
52W Position info
71% above low
Off High info
2.0% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

WST sits 71% above its 52-week low of $211.1.

Summary

West Pharmaceutical Services delivered a strong Q2, with GAAP EPS of $2.15 (up from $1.82) and adjusted EPS of $2.37, beating expectations. Revenue rose 13.8% to $872.3 million, driven by robust demand. The company issued full-year EPS guidance of $8.85-$9.05 and revenue of $3.345B-$3.38B, with the revenue range exceeding consensus. Next quarter guidance calls for EPS of $2.14-$2.24 on revenue of $820M-$835M. This follows a cybersecurity incident in May that was resolved without material impact, and the appointment of a new CEO in June. The strong results and upbeat guidance reinforce the company's growth trajectory in the life sciences sector.

At the time of this announcement, WST was trading at $360.20 on NYSE in the Life Sciences sector, with a market capitalization of approximately $25.3B. The 52-week trading range was $211.10 to $367.66. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.


Price Chart

Share this article

Copied!

WST - Latest Insights

WST
Oct 29, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $416.67
Real-time Price: $390.30 info
Change: -$26.37 (-6%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $410.95
Real-time Price: $390.30 info
Change: -$20.65 (-5%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 7:04 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $410.95
Real-time Price: $390.30 info
Change: -$20.65 (-5%) info
Market Cap: $27.189B info
WST
Oct 29, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $398.00
Real-time Price: $390.30 info
Change: -$7.70 (-2%) info
Market Cap: $27.189B info
WST
Jul 23, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $354.08
Real-time Price: $390.30 info
Change: +$36.22 (+10%) info
Market Cap: $27.189B info